Zimmer set for Smith & Nephew move?
This article was originally published in Clinica
Executive Summary
Media reports this week have suggested that UK medtech firm Smith & Nephew is being targeted by orthopaedics giant Zimmer for a potential takeover. Rumours were rife after S&N's share price went up by 3% in seven trading days on the New York Stock Exchange. The London-based company saw its stock reach $59.34 per share at the close of trading on August 27, up from $57.59 on August 18, suggesting that a bid may be imminent.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals